The combination, termed CagriSema, was submitted to the U.S
Tirzepatide (Mounjaro, Zepbound): A Dual GLP-1/GIP Receptor Agonist for Weight Loss and Diabetes Control In May 2022, tirzepatide was approved for diabetes management under the name Mounjaro, and the FDA expanded this approval to weight loss under the brand name Zepbound in November 2023 (owned by the pharmaceutical company Lilly)
Sustainable weight loss requires long-term commitment and the development of healthy habits
In another study, folate losses during vegetable blanching before freezing amounted to about 10% in broccoli, cauliflower, and green beans, 20% in peas, 26% in spinach, and only 1% in yellow beans 396
Evidence suggests that higher protein intake during weight loss may help preserve lean mass